The ability of the AUC, based on circulating ADAMTS13 levels, to discriminate the presence of OSA was 0.91 (95%CI = 0.87–0.95, P < 0.001), indicating that circulating ADAMTS13 levels are a potential biomarker of OSA. This evidence concerns the gene ADAMTS13 and obstructive sleep apnea syndrome.